4//SEC Filing
Lund-Hansen Torben 4
Accession 0001104659-23-005036
CIK 0001722964other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:44 PM ET
Size
16.3 KB
Accession
0001104659-23-005036
Insider Transaction Report
Form 4
Lund-Hansen Torben
Sr VP & Head of Technical Oper
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-17+35,700→ 35,700 totalExercise: $4.70Exp: 2033-01-17→ Common stock (35,700 underlying) - Award
Common Stock
2023-01-17+17,800→ 17,800 total
Holdings
- 45,662(indirect: By Toluha ApS)
Common Stock
Footnotes (4)
- [F1]Represents 17,800 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 17, 2024, January 17, 2025 and January 17, 2026 subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]Reporting Person is sole member of Toluha ApS.
- [F3]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F4]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2024, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting.
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001753134
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:44 PM ET
- Size
- 16.3 KB